These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33984082)

  • 1. SARS-CoV-2-Induced Severe Immune Thrombocytopenic Purpura.
    Gonze A; Hannesse C; Coppens N; Vellemans H; Maury G
    J Med Cases; 2020 Jun; 11(6):166-168. PubMed ID: 33984082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Thrombocytopenic Purpura in a Patient With SARS-CoV-2 and Epstein-Barr Virus.
    Galestanian A; Suthar KH; Karnath B
    Cureus; 2021 Feb; 13(2):e13615. PubMed ID: 33816014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Thrombocytopenic Purpura Associated with COVID-19 in a Pediatric Patient.
    Marinescu AR; Lazureanu VE; Musta VF; Nicolescu ND; Mocanu A; Cut TG; Muresan CO; Tudoran C; Licker M; Laza R
    Infect Drug Resist; 2022; 15():3405-3415. PubMed ID: 35794926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 induced immune thrombocytopenic purpura: case report.
    Ashraf S; Alsharedi M
    Stem Cell Investig; 2021; 8():14. PubMed ID: 34386543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2.
    Tsao HS; Chason HM; Fearon DM
    Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32439817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune thrombocytopenia preceded by asymptomatic COVID-19 infection].
    Ochiai T; Ando J; Harada S; Hiki M; Ando M; Komatsu N
    Rinsho Ketsueki; 2021; 62(1):58-60. PubMed ID: 33551428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Thrombocytopenic Purpura - Different Presentations in Two COVID-19 Patients.
    Pedroso A; Frade L; Trevas S; Correia MJ; Esteves AL
    Cureus; 2020 Oct; 12(10):e11202. PubMed ID: 33269133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe immune thrombocytopenic purpura after SARS-CoV-2 vaccine.
    Cooper KM; Switzer B
    Arch Clin Cases; 2021; 8(2):31-36. PubMed ID: 34754937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP.
    Jawed M; Khalid A; Rubin M; Shafiq R; Cemalovic N
    Open Forum Infect Dis; 2021 Jul; 8(7):ofab343. PubMed ID: 34307734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic thrombocytopenic purpura in children].
    Gebauer E; Vijatov G
    Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain.
    Mingot-Castellano ME; Alcalde-Mellado P; Pascual-Izquierdo C; Perez Rus G; Calo Pérez A; Martinez MP; López-Jaime FJ; Abalo Perez L; Gonzalez-Porras JR; López Fernández F; Caparrós Miranda IS; González-López TJ; Moreno Beltrán ME; Rubio Escuin R; Jimenez Bárcenas R;
    Br J Haematol; 2021 Aug; 194(3):537-541. PubMed ID: 33991422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic thrombocytopenic purpura as a hematologic manifestation of COVID-19 infection: A case report.
    Laali A; Kermanshah Z; Keyvani H; Kaveh V; Karampoor S
    Respir Med Case Rep; 2021; 34():101534. PubMed ID: 34697584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Immune Thrombocytopenic Purpura Triggered by COVID-19.
    Watts A; Raj K; Gogia P; Toquica Gahona CC; Porcelli M
    Cureus; 2021 Apr; 13(4):e14505. PubMed ID: 34007758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune thrombocytopenic purpura secondary to COVID-19 - case report.
    Petcu AE; Dumitru IM; Cernat RC; Șerban CI; Hangan A; Ghiță E; Vlad ND; Dumitrașcu M; Câmpeanu AT; Rugină S
    Germs; 2021 Jun; 11(2):319-323. PubMed ID: 34422703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic Thrombocytopenic Purpura Related to COVID-19.
    Langhi MM; Abdo ANR; Putz JFB; Carvalho LM; Loss SR; Zampieri Filho JP; Bordin JO; Bachour P; Baiocchi OCCG
    J Med Cases; 2020 Jul; 11(7):204-206. PubMed ID: 33984077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Reactivation of Immune Thrombocytopenic Purpura After SARS-CoV-2 Infection.
    Posa DK; Kamoga GR; Walton R
    Cureus; 2023 Sep; 15(9):e44873. PubMed ID: 37692177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Infection Inducing Immune Thrombocytopenic Purpura: Case Series.
    Guirguis N; Rehman T; Shams Y; Gordon M; Mekhaiel E; Rozell S; Pandya M
    Ochsner J; 2021; 21(2):187-189. PubMed ID: 34239380
    [No Abstract]   [Full Text] [Related]  

  • 18. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
    Al-Husban N; Al-Kuran O
    J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19-induced immune thrombocytopenic purpura; Immunopathogenesis and clinical implications.
    Bahadoram M; Saeedi-Boroujeni A; Mahmoudian-Sani MR; Hussaini H; Hassanzadeh S
    Infez Med; 2022; 30(1):41-50. PubMed ID: 35350251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatic Analysis Underpinning the Frequent Occurrence of Immune Thrombocytopenic Purpura in COVID-19 Patients.
    Frankel AE; Wylie D; Peters B; Marrama D; Ahn C
    Isr Med Assoc J; 2022 May; 24(5):320-326. PubMed ID: 35598057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.